Article Information
vol. 8 no. 2
Published By
Online ISSN
History
- Received September 17, 2021
- Accepted December 5, 2021
- Published online May 3, 2022.
Article Versions
- previous version (January 13, 2022 - 03:27).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Ian D. Pavord1,
- Roland Buhl2,
- Monica Kraft3,
- Charlene M. Prazma4⇑,
- Robert G. Price5,
- Peter H. Howarth6 and
- Steven W. Yancey7
- 1Respiratory Medicine Unit and Oxford Respiratory National Institute for Health Research Biomedical Research Centre, Nuffield Dept of Medicine, Oxford, UK
- 2Pulmonary Dept, Johannes Gutenberg University of Mainz, Mainz, Germany
- 3Dept of Medicine, University of Arizona, Tucson, AZ, USA
- 4Global Respiratory Franchise, GSK, Research Triangle Park, NC, USA
- 5Biostatistics, GSK, Stevenage, Hertfordshire, UK
- 6Respiratory Medical Franchise, GSK, Brentford, UK
- 7Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA
- Charlene M. Prazma (charlene.m.prazma{at}gsk.com)
Article usage
Altmetrics
Vol 8 Issue 2
Table of Contents
Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
